Home > Compound List > Compound details
209216-23-9 molecular structure
click picture or here to close

2-amino-9-[(3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-3H-purin-6-one hydrate

ChemBase ID: 72594
Molecular Formular: C12H17N5O4
Molecular Mass: 295.29448
Monoisotopic Mass: 295.12805405
SMILES and InChIs

SMILES:
n1c([nH]c2c(c1=O)ncn2C1C[C@@H]([C@H](C1=C)CO)O)N.O
Canonical SMILES:
OC[C@@H]1[C@@H](O)CC(C1=C)n1cnc2c1[nH]c(N)nc2=O.O
InChI:
InChI=1S/C12H15N5O3.H2O/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20;/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20);1H2/t6-,7?,8-;/m0./s1
InChIKey:
YXPVEXCTPGULBZ-JBDQBEHPSA-N

Cite this record

CBID:72594 http://www.chembase.cn/molecule-72594.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
2-amino-9-[(3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-3H-purin-6-one hydrate
IUPAC Traditional name
2-amino-9-[(3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one hydrate
Synonyms
Baraclude
Entecavir hydrate
CAS Number
209216-23-9
PubChem SID
162037519
PubChem CID
170342

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID Price
Selleck Chemicals
S1252 external link Add to cart Please log in.
Data Source Data ID
PubChem 170342 external link

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 8.0033045  H Acceptors
H Donor LogD (pH = 5.5) -1.4469311 
LogD (pH = 7.4) -1.5362015  Log P -1.4446591 
Molar Refractivity 71.0008 cm3 Polarizability 26.432161 Å3
Polar Surface Area 125.76 Å2 Rotatable Bonds
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Safety Information Product Information Bioassay(PubChem)
Storage Condition
-20°C expand Show data source
Salt Data
hydrate expand Show data source

DETAILS

DETAILS

Selleck Chemicals Selleck Chemicals
Selleck Chemicals - S1252 external link
Research Area: Hepatitis B
Biological Activity:
Entecavir hydrate is an oral antiviral drug used in the treatment of hepatitis B infection. Entecavir hydrate is a nucleoside analog (more specifically, a guanine analogue) that inhibits reverse transcription, DNA replication and transcription in the viral replication process. Entecavir hydrate is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). Entecavir hydrate is also indicated for the treatment of chronic hepatitis B in adults with HIV/AIDS infection. However, Entecavir hydrate is not active against HIV. [1]

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • http://en.wikipedia.org/wiki/Entecavi
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle